Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrence

Table 3 Univariate analysis of qualitative variables associated with survival in retransplanted patients for hepatitis C virus recurrence

Risk factor	n	Survival estimation			Log-rank P value
		3 yr	5 yr	10 yr
HIV serology
Negative	104	57%	49%	45%	0.006
Positive	4	0%
IS after LT1
Without MMF	82	58%	51%	47%	0.060
With MMF	26	45%	33%	0%
Genotype 1
No	23	69%	69%	69%	0.110
Yes	69	55%	45%	41%
HCV viremia pre-reLT
Negative	14	86%	86%	86%	0.005
Positive	94	50%	41%	36%
Dialysis pre-reLT
Yes	19	74%	67%	67%	0.060
No	89	51%	43%	37%
Split graft at reLT
No	101	57%	48%	44%	0.060
Yes	7	29%	29%	0%
IS after reLT
With tacrolimus	62	67%	57%	53%	0.038
Without tacrolimus	41	43%	37%	30%
Antiviral therapy post-reLT
Yes	35	85%	75%	64%	0.0003
No	63	44%	36%	36%
Antiviral response post-reLT
SVR	14	93%	93%	93%	0.039
Partial or NR	18	77%	59%	43%
FCH post-LT1
No	90	59%	52%	49%	0.018
Yes	18	34%	23%	0%
Arterial complications post-reLT					0.030
No	90	62%	53%	48%
Yes	11	27%	27%	27%
Andres score > 40
No	35	71%	64%	64%	0.019
Yes	67	49%	40%	37%
Reinscription MELD < 25					0.026
No	30	39%	34%	34%
Yes	72	66%	58%	51%

HIV: Human immunodeficiency virus; IS: Immunosuppression; LT1: First liver transplantation; MMF: Mycophenolate mophetil; HCV: Hepatitis C virus; reLT: Liver retransplantation; SVR: Sustained virological response; NR: Non-responder; FCH: Fibrosing cholestatic hepatitis; MELD: Model for End-stage Liver Disease.